The Opportunity:

Revolution Medicines is seeking an Executive Director, Government Affairs, Europe to build and lead the company's government affairs strategy across Europe as the organization prepares for potential oncology launches and a growing regional presence.This leader will be responsible for shaping and executing European government affairs priorities that support patient access, launch readiness, and long-term value for RevMed's innovative oncology portfolio. The role will focus on the evolving EU and country-level policy environment, including oncology access, pricing and reimbursement, HTA, innovation incentives, regulatory and legislative developments, and health system sustainability.

The Executive Director will be a key member of the  Market Access leadership team to ensure that policy insights and external engagement are directly connected to access strategy, HTA planning, reimbursement, country launch sequencing, and stakeholder engagement. The role will partner closely with Corporate Communications / Corporate Affairs, Regulatory, Medical Affairs, Commercial, Legal, Compliance, Patient Advocacy, and global colleagues to ensure consistent and coordinated engagement across the company.

This is a highly strategic, externally facing role for a senior leader who can establish the function, advise the business, represent RevMed credibly with policy stakeholders and industry associations, and translate the European policy landscape into practical business implications and opportunities.

Key Responsibilities:

• Develop and lead the European government affairs strategy in alignment with Market Access, commercial readiness, global policy priorities, and RevMed's mission to serve patients with RAS-addicted cancers.

• Monitor, analyze, and communicate EU and country-level policy developments that may affect oncology innovation, HTA, pricing and reimbursement, patient access, clinical research, diagnostics, data, and launch execution.

• Provide strategic counsel to European and global leadership on policy risks, opportunities, and implications for launch planning, value strategy, access sequencing, and stakeholder engagement.

• Establish and maintain strong working relationships with relevant policymakers, government officials, industry associations, professional organizations, patient organizations, and other external stakeholders, in close coordination with the Patient Advocacy function and consistent with company policies and applicable laws.

• Serve as the policy lead within the Market Access team, ensuring European policy perspectives are embedded into HTA readiness, payer engagement planning, value communication, reimbursement strategy, and country-level access plans.

• Work closely with Corporate Communications / Corporate Affairs to align policy positions, external messaging, reputation considerations, and issues management across European stakeholders.

• Represent RevMed in relevant European and national trade associations, policy forums, and coalitions, and ensure internal teams are informed of key outputs and opportunities for engagement.

• Partner with Legal and Compliance to ensure all government affairs activities comply with applicable rules, transparency requirements, codes of practice, and company standards.

• Establish operating processes, governance, and internal communication mechanisms for the European government affairs function, including policy tracking, stakeholder mapping, briefing materials, and leadership updates.

• Contribute to cross-functional launch readiness and scenario planning by anticipating policy and access barriers and identifying opportunities to support timely and sustainable patient access.

• Partner with global, regional, and affiliate RevMed leadership to develop aligned access plans and to lead a policy and access community, enabling the sharing of best practices, experiences, and priorities across markets.

Required Skills, Experience and Education:

• Bachelor's degree required; advanced degree in public policy, law, political science, health economics, life sciences, public health, or a related field preferred.

• 12+ years of progressive experience in government affairs, public policy, market access, healthcare policy, or related roles within the biopharmaceutical industry, trade associations, government, consulting, or a relevant healthcare organization.

• Demonstrated experience developing and executing government affairs strategies in Europe, including understanding of both EU institutions and national healthcare systems.

• Strong knowledge of European oncology policy, HTA, pricing and reimbursement, market access, innovation policy, and the evolving policy environment affecting medicines and patient access.

• Proven ability to translate complex policy developments into clear strategic implications for access, reimbursement, launch readiness, and business decision-making.

• Existing network within European healthcare policy, oncology policy, access, or biopharmaceutical trade association communities.

• Established credibility engaging with senior internal leaders and external stakeholders, including policymakers, trade associations, patient organizations, and healthcare policy influencers.

• Experience working cross-functionally with Market Access, Corporate Communications / Corporate Affairs, Commercial, Medical Affairs, Regulatory, Legal, Compliance, and global teams.

• Excellent written and verbal communication skills, including the ability to prepare executive briefings, policy positions, stakeholder materials, and concise leadership updates.

• Strong judgment, political acumen, integrity, and ability to operate in a highly regulated environment with appropriate discretion and compliance discipline.

• Ability to thrive in a fast-paced, entrepreneurial biotechnology environment and to build capabilities, processes, and external presence from an early-stage foundation.

Preferred Skills:

• Experience supporting oncology, precision medicine, molecular diagnostics, or highly innovative specialty medicines.

• Prior experience with European launch readiness and country-level access planning in major markets such as Germany, France, Italy, Spain, the United Kingdom, and/or Switzerland.

• Experience working in a smaller or rapidly scaling biotechnology company, including building a new function or operating model.

• Multilingual capability and/or direct experience working across multiple European cultures and healthcare systems.

• Comfort operating at both strategic and hands-on levels, from board or executive-level briefings to detailed policy tracking and stakeholder mapping.

Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact privacy@revmed.com. 

#LI-Hybrid #LI-LO1